| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | 0.026 | 0.5 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.025 | 0.5 |
| mRNA | GSK2126458 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | 0.033 | 0.5 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | PF-4708671 | GDSC1000 | pan-cancer | AAC | -0.024 | 0.5 |
| mRNA | PF-543 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |